SKG三闯IPO，募资前缘何先举债给实控人分红1.7亿

Core Viewpoint - SKG's third attempt to go public reveals significant discrepancies between its founding principles and current operational challenges, including declining revenue, profit, and heavy reliance on a single product, raising questions about its future viability in the capital market [1][2][6]. Group 1: Financial Performance - SKG's revenue decreased from 1.06 billion yuan in 2021 to 900 million yuan in 2022, a year-on-year decline of 14.68% [2] - The net cash flow plummeted from 260 million yuan in 2021 to a negative 1 million yuan [2] - The net profit for SKG dropped from 210 million yuan in 2020 to 100 million yuan in 2022, marking a continuous decline over three years [2][3] Group 2: Product Dependency - SKG heavily relies on its cervical massager, which contributed 586 million yuan, 855 million yuan, and 743 million yuan to revenue from 2019 to 2021, accounting for 74.19%, 86.67%, and 70.33% of total revenue respectively [2] - Revenue from the cervical massager fell from 860 million yuan in 2020 to 450 million yuan in 2022, with its share of total revenue dropping from 86.67% to 50.42% [3] Group 3: Marketing vs. R&D Investment - SKG's marketing expenses from 2020 to 2022 were 210 million yuan, 215 million yuan, and 165 million yuan, consistently over 18% of revenue, totaling approximately 430 million yuan [4] - In contrast, R&D expenses decreased from 9.1% in 2022 to 6.6% in 2025, with a 17.7% year-on-year reduction in 2024 [4][5] - The number of R&D personnel dropped from 172 in 2022 to 161 in 2025, a reduction of over 6% [5] Group 4: Controversial Dividend Practices - SKG controversially borrowed funds to distribute dividends totaling 170 million yuan to shareholders, despite declining revenue and profits [6][7] - The total dividends paid reached 280 million yuan, accounting for 74% of net profit during the reporting period [7] - The company's interest-bearing loans surged from 173,000 yuan at the end of 2022 to 1.8 billion yuan by the third quarter of 2025 [8] Group 5: Market Competition and Future Outlook - The massage device market in China experienced a compound annual growth rate of 11.05% from 2015 to 2021, with increasing competition from brands like Xiaomi and Beiliang, intensifying price wars [8] - Analysts suggest that SKG's brand longevity will depend on its ability to build core competitiveness beyond marketing [9]